Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit
ObjectivesTo investigate the prognostic significance of the systemic immune-inflammation index (SII) in patients after radical cholecystectomy for gallbladder cancer (GBC) using overall survival (OS) as the primary outcome measure.MethodsBased on data from a multi-institutional registry of patients...
Main Authors: | Lin Li, Tai Ren, Ke Liu, Mao-Lan Li, Ya-Jun Geng, Yang Yang, Huai-Feng Li, Xue-Chuan Li, Run-Fa Bao, Yi-Jun Shu, Hao Weng, Wei Gong, Wan Yee Lau, Xiang-Song Wu, Ying-Bin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.692647/full |
Similar Items
-
Case report: A de novo ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib
by: Jing-Xiao Yang, et al.
Published: (2023-03-01) -
Triptolide Induces S Phase Arrest and Apoptosis in Gallbladder Cancer Cells
by: Yun-Ping Hu, et al.
Published: (2014-02-01) -
Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells
by: Shan-Shan Xiang, et al.
Published: (2014-08-01) -
Correction: Xiang, S., et al. Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells. Molecules 2014, 19, 13235–13250
by: Shan-Shan Xiang, et al.
Published: (2016-05-01) -
Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX.
by: Tian-Yu Liu, et al.
Published: (2015-01-01)